Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
41.12    -1.44 (-3.38%)
Bid:
41.06
Ask:
43.48
Spread: 2.42 (5.894%)
Market Cap: £416.42m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Statement from Executive Chairman, Lawrence Stroll

20 Apr 2020 07:05

RNS Number : 1127K
Aston Martin Lagonda Global Hld PLC
20 April 2020
 

20 April 2020

 

Aston Martin Lagonda Global Holdings plc

("Aston Martin Lagonda", the "Company" or the "Group")

 

Statement from Executive Chairman, Lawrence Stroll

 

"I am truly excited to be taking on the role of Executive Chairman of this great British company, Aston Martin Lagonda. In the midst of the most challenging environment, globally, that any of us have ever experienced, all of my and the management team's energies will now be dedicated to building on the inherent strengths of the Company, its Brand, engineering, and the skills of its people to forge the foundations of a bright future. Our ambition for the Company is significant, clear and only matched by our determination to succeed. The rights issue and the investment that I, and my co-investors in the consortium, have made has underpinned the financial security of, and our confidence in, the business. We can now focus on the engineering and marketing programmes that will enable Aston Martin to become one of the preeminent luxury car brands in the world.

 

In this first year we will reset the business. Our most pressing objective is to plan to restart our manufacturing operations, particularly to start production of the brand's first SUV, DBX, and to bring the organisation back to full operating life. We will do this in a way that ensures we will protect our people, wherever they work - their safety is our overwhelming concern. Alongside the return to production, we will be undertaking the necessary rebalancing of supply to demand for our core models. In the months ahead, as the world starts to emerge from the Covid-19 pandemic, we will start to reinvigorate our marketing initiatives to continue to build our order book. In 2021, Aston Martin will take its place on the Formula 1TM Grid as a highly competitive Works team for the first time in over 60 years. This will give us a significant global marketing platform to strengthen our Brand and engage with our customers and partners across the world.

 

We will continue to focus significant effort and investment into the continued development of our range of mid-engined cars. These are a crucial next stage in the expansion of our product line-up. Descended from the awesome Aston Martin Valkyrie hypercar, the Valhalla and Vanquish are set to position Aston Martin firmly in this sector and complete our range of highly engineered and beautiful sports cars. In the longer term we intend to commit to producing electric cars to combine performance and luxury with environmental sustainability.

 

There is a hugely exciting opportunity for Aston Martin, and an enormous amount of hard work to be done to achieve our ambitions. I have spent the past few weeks getting to know the business and new colleagues. I have been impressed with their passion, dedication and craftsmanship in making our beautiful cars. I am also impressed by and hugely appreciative of the significant efforts being made by everyone at Aston Martin Lagonda to support the business as we manage through this uncertain time, including our proud contribution to supporting the NHS through the development and manufacture of much needed personal protective equipment (PPE). I am confident that collectively we have the skills, the brand, the product and the financial strength to achieve those ambitions over time. When we do, we will have built Aston Martin into the highly valued company that it should be, and in which our customers, staff, partners and shareholders will share with pride.

 

Finally, I would like to express my sincere thanks to Penny Hughes and her colleagues on the Board for all that they have done in recent months to secure the rights issue and our investment, thereby safeguarding the future of the Company. They have all been professional, thorough and considered throughout our engagement with the Board and played a significant part in giving my co-investors and me, the confidence to support this fundraising. The process to identify and appoint new Independent NEDs is under way. As Executive Chairman I look forward to working for the benefit of all shareholders and stakeholders."

 

 

Enquiries

Investors and Analysts

Charlotte Cowley

Director of Investor Relations

+44 (0)7771 976764

charlotte.cowley@astonmartin.com

Media

Kevin Watters

Director of Communications

+44 (0)7764 386683

kevin.watters@astonmartin.com

Toby Bates

Senior Adviser, Financial Communications

+44 (0)7584 773837

toby.bates1@astonmartin.com

Grace Barnie

Corporate Communications Manager

+44 (0)7880 903490

grace.barnie@astonmartin.com

Brunswick

Dan Roberts

+44 (0)20 7404 5959

Diana Vaughton

astonmartin@brunswick.com

Tulchan Communications

Communications Adviser to the Consortium

+44 (0)20 7353 4200

Martin Robinson

Simon Pilkington

Harry Cameron

 

No representations or warranties, express or implied, are made as to, and no reliance should be placed on, the accuracy, fairness or completeness of the information presented or contained in this release. This release contains certain forward-looking statements, which are based on current assumptions and estimates by the management of Aston Martin Lagonda Global Holdings plc ("Aston Martin Lagonda"). Past performance cannot be relied upon as a guide to future performance and should not be taken as a representation that trends or activities underlying past performance will continue in the future. Such statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from any expected future results in forward-looking statements. These risks may include, for example, changes in the global economic situation, and changes affecting individual markets and exchange rates.

 

Aston Martin Lagonda provides no guarantee that future development and future results achieved will correspond to the forward-looking statements included here and accepts no liability if they should fail to do so. Aston Martin Lagonda undertakes no obligation to update these forward-looking statements and will not publicly release any revisions that may be made to these forward-looking statements, which may result from events or circumstances arising after the date of this release.

 

This release is for informational purposes only and does not constitute or form part of any invitation or inducement to engage in investment activity, nor does it constitute an offer or invitation to buy any securities, in any jurisdiction including the United States, or a recommendation in respect of buying, holding or selling any securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCILMJTMTIBBPM
Date   Source Headline
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results
30th Sep 20247:00 amRNSTrading Update and adjustment to FY 2024 guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.